Business Update

Tripos receives payment from Chronogen for drug discovery for age-related disease

Published in Drug Week, July 28th, 2006

Tripos, Inc. (TRPS), a provider of drug discovery chemistry and informatics products and services, announced that Tripos Discovery Research, Ltd. (TDR), based in Bude, England, has secured an undisclosed milestone payment from Chronogen Inc. as a result of a small-molecule drug discovery collaboration progressing into preclinical development.

Chronogen is a drug discovery company developing therapeutics to treat highly prevalent age-dependent diseases.

The multiyear collaboration between Tripos and Chronogen, which was announced January 2004, combines Tripos' expertise in therapeutic medicinal chemistry and proprietary informatics tools with...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Week

Source: Drug Week (2006-07-28)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry